Mycophenolate mofetil in epidermolysis bullosa acquisita.
Lutz
L
Kowalzick
Susanne
S
Suckow
Heidrun
H
Ziegler
Thomas
T
Waldmann
Jörg-Martin
JM
Pönnighaus
Volkmar
V
Gläser
D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016107:Epidermolysis Bullosa Acquisita / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010956:Plasmapheresis / Q000379:methods*; D011239:Prednisolone / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D011239:Prednisolone; D009173:Mycophenolic Acid